Auzzi Shopping

The Times Real Estate

.

Today's Features at Auzzi

Pipe Relining Solutions for Strata, Real Estate & Builders—Less Mess, More Value

If you manage properties, build them, or sell them—pipe issues are the last thing you need. At Revolution Pipe Relining, we get it. Burst drains, tree root invasions, and collapsing pipe...

How to Grow and Care for a Dragon Tree (Dracaena draco)

Dragon trees are among those plants that come with a steep price tag. While they're pricier than many succulent trees, they're ultimately proven to be worth the investment because of their...

The Ethics of AI Sales Calls: Where Do We Draw the Line?

AI sales calls are becoming a reality for outbound marketing. AI can utilize natural language processing and voice modulation to follow a script, respond to inquiries, and create the sembl...

Why Eversys Coffee Machines Are Taking Aussie Cafés by Storm

Introduction In the world of modern coffee service, consistency, speed, and quality are no longer luxuries — they’re expectations. As cafés, restaurants and workplaces across Austral...

China Eastern Air Logistics Launches South Australia Portfolio Mix in Adelaide

China Eastern Air Logistics launched its South Australia product portfolio at Adelaide Ayers House, Australia, on April 11. A procurement MOU between China Eastern Airlines Cold Chain and ...

The Rise of Mobile Mechanics: Why More Aussies Are Getting Their Car Serviced at Home

Once upon a time, getting your car serviced meant sitting around a dusty workshop with a stale coffee in hand. Now, thanks to businesses like the leading mobile mechanic in Sydney, Aussies...

Does My Sydney Business Need A Google Ads Agency?

Fair dinkum, operating a business in Harbour City can make you feel like you're battling upstream the whole time. You've got a ripper product or service, your site looks good, and you're w...

Interpharma Investments Limited Appoints Alfonso "Chito" Zulueta As Non-Executive Chairman

  • Written by Auzzi Shopping

SINGAPORE - Media OutReach - 5 May 2023 - Interpharma Investments Limited, holding company of leading healthcare services provider Zuellig Pharma, today announced the appointment of Mr. Alfonso "Chito" Zulueta as Non-Executive Chairman of its Board.

Effective 1 June 2023, Mr. Zulueta succeeds Mr. Patrick Davies, who stepped down after serving as Non-Executive Chairman for four years.

Mr. Zulueta joins Interpharma Investments Limited with more than three decades of experience with Eli Lilly and Company, where he was most recently President of Lilly International, and an Executive Committee member and Corporate Officer prior to his retirement in 2021. He has a strong track record in the pharmaceutical industry and extensive experience on corporate boards and industry associations. During his career with Eli Lilly and Company, he held both regional, U.S. and global roles across various functional areas including sales, marketing, product and business development, operations, and general management.

Mr. Zulueta said, "Zuellig Pharma plays a unique role in the healthcare landscape in Asia, as an innovative partner in many areas across distribution and commercialisation solutions. With its rich, proven legacy and a spirit of resilience, entrepreneurship and depth, the company is well-placed for an exciting future. Patrick has been exceptional in helping steer the business through a solid period of growth. I look forward to continuing his legacy and contributing to the company's strategy to help achieve its mission of making healthcare more accessible in Asia."

Under Mr. Davies' leadership, Zuellig Pharma overcame a period of uncertainty and significant challenges brought about by the pandemic, including major disruptions to supply chains and pressures on healthcare systems worldwide. Mr. Davies steered the company through an important business transformation, cementing its position as an indispensable partner to the company's key stakeholders and the communities it serves in Asia.

Mr. Davies said, "The company's success in weathering massive challenges over the past four years is a true testament of our capabilities, collective resilience and commitment towards building a healthier future for Asia. It brings me great pride to have been part of this journey and I look forward to seeing Zuellig Pharma scale greater heights in the years to come."

Interpharma Investments Limited expresses its sincerest gratitude to Mr. Davies for his valuable contribution to the Board during his four-year term and extends its warmest welcome to Mr. Zulueta.

Hashtag: #ZuelligPharma #InterpharmaInvestmentsLimited #Healthcare #Appointment


The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma

Zuellig Pharma (a subsidiary of Interpharma Investments Limited) is one of the largest healthcare services groups in Asia and our mission is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become an over US$15 billion business covering 16 markets with over 13,000 employees. Our people serve over 350,000 medical facilities and work with over 500 clients, including the top 20 pharmaceutical companies in the world.